Logged Activity – AC-160105-085 – 160419 – CleverCap CxO BRIEFINGS
Coordinate a series of CxO Briefings to introduce CleverCap to healthcare
systems and hospitals.
Assigned Task – AC-150513-054 – 160420 – ENTRAKIT CxO BRIEFINGS
Coordinate a series of CxO Briefings to introduce EntraKits to health care
systems and hospitals.
Opportunity Alert – AC-150513-054 – QUINTILES
Quintiles works with many of the leading biopharmaceutical and other life
science companies. Their core clinical solutions and services that include
project management and clinical monitoring functions for conducting
multi-site Phase II-IV trials.
Logged Activity – AC-150513-054 – 160419 – 3Q SALES
Entra sales call with Rick, Michele and Matt.
Opportunity Alert – AC-150513-054 – Medstar Institute of Innovation
David Brennan, Director of Innovation, Medstar Institute of Innovation
Opportunity Alert – AC-150513-054 – LCF Research/NMHIC
New Mexico Health Information Collaborative (NMHIC) (New Mexico) is
interesting in discussing NIH grant pursuit.
Opportunity Alert – AC-150513-054 – Target Health Clinical Trial RPM
Target Health Inc., is a full-service e*CRO committed to improving the way
companies run clinical trials. They have successfully used Target e*CRF in
over 300 clinical trials.
Opportunity Alert – AC-150513-054 – RPM/Rural Health SBIR Grant
University of Texas Nursing School is interested in collaborating on a
rural health diabetes remote patient monitoring research grant
application.
Opportunity Alert – AC-150513-054 – Longitudinal Biometric Registries
There is a growing interest among in using patient registries to monitor
safety and track outcomes. Research funding continues to grow for creating,
maintaining, and extending the value of patient registries.
Opportunity Alert – AC-150513-054 – Tribal Population Research Grants
The National Telehealth Technology Assessment Resource Center (TTAC) and
Alaska eHealth Network (AeHN) have Native American tribal populations that
may strengthen our research grant applications beyond just rural health.